SARS CoV 2 News and Research

RSS

CEPI and HMRI partner to accelerate development of pandemic vaccines

CEPI, the Coalition for Epidemic Preparedness Innovations, and the Houston Methodist Research Institute (HMRI), have today announced a partnership to combine cutting-edge artificial intelligence (AI) technology with established laboratory techniques to speed up development of future vaccines against novel viral threats (also known as Disease X).

18 Jul 2023

Immunodiagnosis: Unleashing the potential of personalized immunotherapy

Researchers discuss the concept of immunodiagnosis and explores the potential of artificial intelligence in ID systems for precise tumor immunotherapy.

18 Jul 2023

Merck awards 2023 Future Insight Prize for research into air sensor to detect pandemic pathogens

Merck KGaA, Darmstadt, Germany, awarded its 2023 Future Insight Prize to Khalid Salaita, professor of chemistry at Emory University. The award comes with $540,000 to fund the next phase of research into an air sensor that can continuously monitor indoor spaces for pathogens that can cause pandemics.

17 Jul 2023

Babies have a 'secret weapon' that helps to fight new pathogens

A pair of new studies led by researchers at Columbia University explains why babies get so many common respiratory infections and identifies a specialized cluster of immune cells found only in babies that help them better cope with new pathogens.

17 Jul 2023

Omicron subvariant BA.5 can cause more severe disease

Omicron-derived virus variants are currently responsible for most SARS-CoV-2 infections worldwide. Compared to earlier virus variants, Omicron rarely causes severe disease.

17 Jul 2023

Unveiling long COVID: new study explores symptoms and strain variations

Researchers investigated the variation in the clinical and demographic characteristics of acute SARS-CoV-2.

17 Jul 2023

Did patterns of US ED visits and mental health–related ED visits change during the COVID-19 pandemic?

People without mental health conditions had higher numbers of emergency department visits during the COVID-19 pandemic.

17 Jul 2023

Boosted immunity: Delta and Omicron-BA.1 infections enhance protection in vaccinated patients

Researchers examined the immune response and potential cross-protection in hospitalized patients with breakthrough infections.

17 Jul 2023

Neighborhood environment can increase risk of COVID-19 hospitalization, study reveals

The range of COVID-19 symptoms varies - some feel a mild cold, others are hospitalized, while others perish. Many studies have linked the severity of COVID-19 symptoms with an individual's biological factors, but less is known about the impact of non-biological factors, such as the environment in which people live.

14 Jul 2023

COVID antiviral treatments underused in nursing homes, study finds

Nursing homes were a key battleground during the COVID pandemic and prioritized for distribution of PPE, vaccines, and COVID testing kits.

14 Jul 2023

Australian researchers discover how COVID-19 can infect the human placenta

In a landmark study published in Nature Cell Biology, Australian researchers, led by Professor Jose Polo from Monash University and the University of Adelaide and University of Melbourne's Professor Kanta Subbarao from the Peter Doherty Institute for Infection and Immunity (Doherty Institute), have revealed how COVID-19 can infect the human placenta.

14 Jul 2023

Unveiling the key defender: PLSCR1 identified as a potent anti-SARS-CoV-2 factor in COVID-19 immunity

Researchers identified the anti-SARS-CoV-2 function of phospholipid scramblase 1 (PLSCR1).

14 Jul 2023

Novel approach: intranasal vaccination strategy targets Omicron COVID-19 variants

Researchers tested the efficacy of a two to three-dose intranasal (IN) regimen of the NDV-HXP-S vaccine.

14 Jul 2023

INTEGRA pipetting solutions accelerate crucial viral genomics research

The Center for Emerging Viral Threats (CEVT) in Louisiana, USA, is using INTEGRA Biosciences’ liquid handling solutions for COVID-19 testing and viral genomics studies.

From INTEGRA Biosciences 14 Jul 2023

Study sheds light on how COVID-19 infection may lead to late pregnancy complications

The Hong Kong University of Science and Technology (HKUST) and The Chinese University of Hong Kong (CUHK) today unveiled ground-breaking research that sheds light on how COVID-19 infection may lead to late pregnancy complications.

13 Jul 2023

Investigating the role of T-cell immunity in long COVID

Researchers investigates the persistence of symptoms and the immune response in patients recovering from COVID-19.

13 Jul 2023

pAQ monitor: innovative device provides real-time surveillance of SARS-CoV-2 aerosols

Researchers presented the proof-of-concept of a pathogen Air Quality (pAQ) monitor.

13 Jul 2023

Government seeks views on proposed changes to the Health Protection Notification Regulations 2010

The Health Protection Notification Regulations 2010 (HPNR) help us respond promptly to suspected cases of infectious disease that could have an impact on public health.

13 Jul 2023

IL-9 identified as contributor to viral spread and airway inflammation in COVID-19

Researchers used a K18-hACE2 transgenic (ACE2.Tg) mouse model to demonstrate that interleukin-9 (IL-9).

13 Jul 2023

COVID-19 excess mortality measured by the Global Health Security Index

Researchers compare COVID-19 excess mortality rates across 183 countries.

13 Jul 2023

SARS CoV 2 News and Research

CEPI and HMRI partner to accelerate development of pandemic vaccines

Immunodiagnosis: Unleashing the potential of personalized immunotherapy

Merck awards 2023 Future Insight Prize for research into air sensor to detect pandemic pathogens

Babies have a 'secret weapon' that helps to fight new pathogens

Omicron subvariant BA.5 can cause more severe disease

Unveiling long COVID: new study explores symptoms and strain variations

Did patterns of US ED visits and mental health–related ED visits change during the COVID-19 pandemic?

Boosted immunity: Delta and Omicron-BA.1 infections enhance protection in vaccinated patients

Neighborhood environment can increase risk of COVID-19 hospitalization, study reveals

COVID antiviral treatments underused in nursing homes, study finds

Australian researchers discover how COVID-19 can infect the human placenta

Unveiling the key defender: PLSCR1 identified as a potent anti-SARS-CoV-2 factor in COVID-19 immunity

Novel approach: intranasal vaccination strategy targets Omicron COVID-19 variants

INTEGRA pipetting solutions accelerate crucial viral genomics research

Study sheds light on how COVID-19 infection may lead to late pregnancy complications

Investigating the role of T-cell immunity in long COVID

pAQ monitor: innovative device provides real-time surveillance of SARS-CoV-2 aerosols

Government seeks views on proposed changes to the Health Protection Notification Regulations 2010

IL-9 identified as contributor to viral spread and airway inflammation in COVID-19

COVID-19 excess mortality measured by the Global Health Security Index

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News